Defining central themes in breast cancer biology by differential proteomics: conserved regulation of cell spreading and focal adhesion kinase.

Breast cancer is a highly heterogeneous disease, an observation that underscores the importance of elucidating conserved molecular characteristics, such as gene and protein expression, across breast cancer cell types toward providing a greater understanding of context-specific features central to this disease. Motivated by the goal of defining central biological themes across breast cancer cell subtypes, we conducted a global proteomic analysis of three breast cancer cell lines, MCF7, SK-BR-3, and MDA-MB-231, and compared these to a model of nontransformed mammary cells (MCF10A). Our results demonstrate modulation of proteins localized to the extracellular matrix, plasma membrane, and nucleus, along with coordinate decreases in proteins that regulate "cell spreading," a cellular event previously shown to be dysregulated in transformed cells. Protein interaction network analysis revealed the clustering of focal adhesion kinase (FAK), a fundamental regulator of cell spreading, with several proteins identified as mutually, differentially abundant across breast cancer cell lines that impact expression and activity of FAK, such as neprilysin and keratin 19. These analyses provide insights into conservation of protein expression across breast cancer cell subtypes, a subset of which warrants further investigation for their roles in the regulation of cell spreading and FAK in breast cancer.

[1]  In‐San Kim,et al.  Identification of Motifs for Cell Adhesion within the Repeated Domains of Transforming Growth Factor-β-induced Gene,βig-h3 * , 2000, The Journal of Biological Chemistry.

[2]  B. Konety,et al.  Nuclear structural proteins as biomarkers of cancer , 1999, Journal of cellular biochemistry.

[3]  Emilio Marengo,et al.  The principle of exhaustiveness versus the principle of parsimony: a new approach for the identification of biomarkers from proteomic spot volume datasets based on principal component analysis , 2010, Analytical and bioanalytical chemistry.

[4]  S. Bao,et al.  The multifaceted role of periostin in tumorigenesis , 2009, Cellular and Molecular Life Sciences.

[5]  J. Russo,et al.  Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. , 1990, Cancer research.

[6]  C. Streuli,et al.  Control of Normal Mammary Epithelial Phenotype by Integrins , 1998, Journal of Mammary Gland Biology and Neoplasia.

[7]  M. Humphries,et al.  Cell adhesion to fibrillin-1: identification of an Arg-Gly-Asp-dependent synergy region and a heparin-binding site that regulates focal adhesion formation , 2007, Journal of Cell Science.

[8]  G. Watkins,et al.  Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance. , 2006, International journal of oncology.

[9]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[10]  M. Hegi,et al.  Combined lysophosphatidic acid/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment. , 2008, Cancer research.

[11]  B. Flaxman,et al.  Growth of normal human mammary gland epithelium in vitro. , 1972, Cancer research.

[12]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[13]  Richard D. Smith,et al.  Quantitative proteome analysis of breast cancer cell lines using 18O‐labeling and an accurate mass and time tag strategy , 2006, Proteomics.

[14]  E. Gelmann,et al.  Differentiation state and invasiveness of human breast cancer cell lines , 2004, Breast Cancer Research and Treatment.

[15]  T. Orfeo,et al.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. , 1977, Journal of the National Cancer Institute.

[16]  F. Giancotti,et al.  Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling. , 2000, The Journal of clinical investigation.

[17]  Mina J. Bissell,et al.  Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging , 2008, Histochemistry and Cell Biology.

[18]  K. Das,et al.  Coordinate loss of fibroblast growth factor 2 and laminin 5 expression during neoplastic progression of mammary duct epithelium. , 2007, Human pathology.

[19]  M. Kern,et al.  Angiotensin II, Focal Adhesion Kinase, and PRX1 Enhance Smooth Muscle Expression of Lipoma Preferred Partner and its Newly Identified Binding Partner Palladin to Promote Cell Migration , 2007, Circulation research.

[20]  Michael K. Wendt,et al.  Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasis , 2009, Breast Cancer Research.

[21]  C. Fenoglio-Preiser,et al.  Ultrastructural and Immunocytochemical Features of Ovarian Tumors , 1986 .

[22]  David G Camp,et al.  Comparison of normal and breast cancer cell lines using proteome, genome, and interactome data. , 2005, Journal of proteome research.

[23]  K. Midwood,et al.  J. Cell Commun. Signal. (2009) 3:287–310 DOI 10.1007/s12079-009-0075-1 RESEARCH ARTICLE The role of tenascin-C in tissue injury and tumorigenesis , 2009 .

[24]  D. Horsfall,et al.  Expression of Extracellular Matrix Components Versican, Chondroitin Sulfate, Tenascin, and Hyaluronan, and Their Association with Disease Outcome in Node-Negative Breast Cancer , 2004, Clinical Cancer Research.

[25]  R. Cardiff,et al.  Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression , 2007, Proceedings of the National Academy of Sciences.

[26]  Pierre Legrain,et al.  Comprehensive Proteomic Analysis of Breast Cancer Cell Membranes Reveals Unique Proteins with Potential Roles in Clinical Cancer* 210 , 2003, The Journal of Biological Chemistry.

[27]  T. Hei,et al.  BigH 3 protein expression as a marker for breast cancer , 2008 .

[28]  F. Bertucci,et al.  Gene expression profiling of breast cell lines identifies potential new basal markers , 2006, Oncogene.

[29]  S. Weitzman,et al.  The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis. , 1997, Journal of cell science.

[30]  C. Rüegg,et al.  Tenascin‐C inhibits β1 integrin‐dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1 – 5 repeats to fibronectin , 1999, European journal of immunology.

[31]  Lauren Summers,et al.  Adhesion to fibronectin regulates interleukin-1 beta expression in microglial cells , 2009, Molecular and Cellular Neuroscience.

[32]  M. Brattain,et al.  A novel role of ERK5 in integrin‐mediated cell adhesion and motility in cancer cells via Fak signaling , 2009, Journal of cellular physiology.

[33]  A. Kaneda,et al.  Identification of silencing of nine genes in human gastric cancers. , 2002, Cancer research.

[34]  Junsheng Li,et al.  The expression analysis of periostin in human breast cancer. , 2010, The Journal of surgical research.

[35]  K. Horiuchi,et al.  Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  Honghao Li,et al.  [Inhibitory effects of transfection of arresten gene on liver metastasis from colorectal cancer in nude mice]. , 2008, Ai zheng = Aizheng = Chinese journal of cancer.

[37]  Yi-Wen Chen,et al.  Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis. , 2010, Journal of proteome research.

[38]  W. Gerald,et al.  Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. , 2009, The Journal of clinical investigation.

[39]  Tatjana Crnogorac-Jurcevic,et al.  Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer Mechanism , 2006, PLoS medicine.

[40]  W. Hancock,et al.  An approach to the proteomic analysis of a breast cancer cell line (SKBR‐3) , 2003, Proteomics.

[41]  L. Kiesel,et al.  On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer , 2007, Breast Cancer Research and Treatment.

[42]  S. Kuo,et al.  Anthrax toxin: pathologic effects on the cardiovascular system. , 2009, Frontiers in bioscience.

[43]  H. Iizuka,et al.  Focal adhesion kinase as an immunotherapeutic target , 2009, Cancer Immunology, Immunotherapy.

[44]  S. Jeffrey,et al.  Transcriptomic signatures in breast cancer. , 2007, Molecular bioSystems.

[45]  Goberdhan P Dimri,et al.  Mammary epithelial cell transformation: insights from cell culture and mouse models , 2005, Breast Cancer Research.

[46]  Burton B. Yang,et al.  β1-Integrin-mediated Glioma Cell Adhesion and Free Radical-induced Apoptosis Are Regulated by Binding to a C-terminal Domain of PG-M/Versican* , 2002, The Journal of Biological Chemistry.

[47]  Micah Dembo,et al.  Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. , 2007, The international journal of biochemistry & cell biology.

[48]  C. Turner,et al.  Hic‐5 contributes to epithelial‐mesenchymal transformation through a RhoA/ROCK‐dependent pathway , 2007, Journal of cellular physiology.

[49]  M. Dembo,et al.  Substrate flexibility regulates growth and apoptosis of normal but not transformed cells. , 2000, American journal of physiology. Cell physiology.

[50]  Ma-Kang-Zhuo Bai Canstatin,a novel matrix-derived inhibitor of angiogenesis and tumor growth , 2003 .

[51]  Steven P Gygi,et al.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.

[52]  K. Nose,et al.  Hic-5-Reduced Cell Spreading on Fibronectin: Competitive Effects between Paxillin and Hic-5 through Interaction with Focal Adhesion Kinase , 2001, Molecular and Cellular Biology.

[53]  Y. Hoshikawa,et al.  A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry. , 2008, Biomedical chromatography : BMC.

[54]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[55]  Michael L. Gatza,et al.  A pathway-based classification of human breast cancer , 2010, Proceedings of the National Academy of Sciences.

[56]  Sami Alom Ruiz,et al.  An inhibitory role for FAK in regulating proliferation: a link between limited adhesion and RhoA-ROCK signaling , 2006, The Journal of cell biology.

[57]  P. Kenemans,et al.  Oncogenic pathways in hereditary and sporadic breast cancer. , 2004, Maturitas.

[58]  R. Weichselbaum,et al.  Anti-angiogenic cues from vascular basement membrane collagen. , 2000, Cancer research.

[59]  S. Souchelnytskyi Proteomics in Studies of Signal Transduction in Epithelial Cells , 2002, Journal of Mammary Gland Biology and Neoplasia.

[60]  A. Saltiel,et al.  Identification of CAP as a costameric protein that interacts with filamin C. , 2007, Molecular biology of the cell.

[61]  L. Engel,et al.  Human breast carcinoma cells in continuous culture: a review. , 1978, Cancer research.

[62]  U. Sauer,et al.  Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx. , 1998, Anticancer research.

[63]  Daohai Zhang,et al.  Cytokeratin 19 regulates endoplasmic reticulum stress and inhibits ERp29 expression via p38 MAPK/XBP-1 signaling in breast cancer cells. , 2009, Experimental cell research.

[64]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. Klagsbrun,et al.  Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[66]  E. Diamandis,et al.  Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines , 2007, Molecular & Cellular Proteomics.

[67]  D. DeFranco,et al.  Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator. , 2006, Molecular endocrinology.

[68]  D. Dabbs,et al.  Erratum: Immunohistochemical Surrogate Markers of Breast Cancer Molecular Classes Predicts Response to Neoadjuvant Chemotherapy , 2011 .

[69]  M. Lacroix,et al.  Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update , 2004, Breast Cancer Research and Treatment.

[70]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[71]  M. Stack,et al.  Processing of Laminin-5 and Its Functional Consequences: Role of Plasmin and Tissue-type Plasminogen Activator , 1998, The Journal of cell biology.

[72]  Jeffrey C. Allen,et al.  Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase. , 2002, Cancer research.

[73]  J. Guan,et al.  Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. , 2010, Cancer letters.

[74]  C. Streuli,et al.  Adhesion-Mediated Signaling in the Regulation of Mammary Epithelial Cell Survival , 1999, Journal of Mammary Gland Biology and Neoplasia.

[75]  G. Edelman,et al.  Multiple integrins mediate cell attachment to cytotactin/tenascin. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[76]  J. Pringle,et al.  Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms , 2009, Breast Cancer Research.

[77]  S. O’Brien,et al.  Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. , 1983, Cancer research.

[78]  Y. Hathout,et al.  Proteomic phenotyping: metastatic and invasive breast cancer. , 2004, Cancer letters.

[79]  V. Faundez,et al.  Anthrax Toxin Receptor 1/Tumor Endothelium Marker 8 Mediates Cell Spreading by Coupling Extracellular Ligands to the Actin Cytoskeleton* , 2006, Journal of Biological Chemistry.

[80]  Rosamonde E Banks,et al.  Housekeeping proteins: A preliminary study illustrating some limitations as useful references in protein expression studies , 2005, Proteomics.

[81]  A. Aszódi,et al.  α11β1 Integrin-Dependent Regulation of Periodontal Ligament Function in the Erupting Mouse Incisor , 2007, Molecular and Cellular Biology.

[82]  B. Gusterson,et al.  Cell–matrix interactions during development and apoptosis of the mouse mammary gland in vivo , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.

[83]  N. Boudreau,et al.  Extracellular matrix and integrin signalling: the shape of things to come. , 1999, The Biochemical journal.

[84]  M. Slijper,et al.  Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer , 2009, Breast Cancer Research.

[85]  M. Gilcrease,et al.  Integrin signaling in epithelial cells. , 2007, Cancer letters.

[86]  W. Hahn,et al.  Modelling the molecular circuitry of cancer , 2002, Nature Reviews Cancer.

[87]  H. Hondermarck,et al.  Functional Proteomics of Breast Cancer for Signal Pathway Profiling and Target Discovery , 2002, Journal of Mammary Gland Biology and Neoplasia.

[88]  E. Madrigal-Bujaidar,et al.  Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women. , 2006, Cancer genetics and cytogenetics.

[89]  J. Mier,et al.  Canstatin Inhibits Akt Activation and Induces Fas-dependent Apoptosis in Endothelial Cells* , 2003, Journal of Biological Chemistry.

[90]  Anita Tandle,et al.  Antiangiogenic gene therapy of cancer: recent developments , 2004, Journal of Translational Medicine.

[91]  Zhu Chen,et al.  Palladin regulates cell and extracellular matrix interaction through maintaining normal actin cytoskeleton architecture and stabilizing Beta1‐integrin , 2007, Journal of cellular biochemistry.

[92]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[93]  P. Leder,et al.  Human MCF10A Mammary Epithelial Cells Undergo Apoptosis following Actin Depolymerization That Is Independent of Attachment and Rescued by Bcl-2 , 2001, Molecular and Cellular Biology.

[94]  A. Howell,et al.  Origins of breast cancer subtypes and therapeutic implications , 2007, Nature Clinical Practice Oncology.

[95]  Daniel Levy,et al.  A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study , 2007, BMC Medical Genetics.

[96]  M. Kuroda,et al.  Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome , 2002, Virchows Archiv.

[97]  Manuel Théry,et al.  The Universal Dynamics of Cell Spreading , 2007, Current Biology.

[98]  P. Drew,et al.  The proteomic analysis of cisplatin resistance in breast cancer cells. , 2007, Oncology research.

[99]  R. Beroukhim,et al.  Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.